Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Biomed Biotechnol ; 2010: 231832, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20339509

RESUMO

The myocardial reperfusion following ischemia leads to the ischemic vasodilation by affecting the release of various vasoactive substances, such as free radicals, NO, and histamine. In addition, some evidences suggest that glucagon itself may alter the release of those substances. In this study, we investigated the ischemic vasodilation of the isolated rat heart, as well as the concentrations of NO, TBARS, and histamine in the coronary venous effluent either in the presence or in the absence of glucagon. Our results showed that in the presence of glucagon, there was a faster restoration of coronary perfusion pressure during ischemic vasodilation compared to the absence of glucagon (124 +/- 5.6 versus 81 +/- 5.2 s) with no apparent changes in TBARS concentration. The glucagon's administration leads to the decreased release of histamine by approximately 35%. Biphasic release of NO in the presence of glucagon initially showed augmentation by 60%, followed by the significant attenuation of 45%.


Assuntos
Vasos Coronários/efeitos dos fármacos , Glucagon/farmacologia , Coração/efeitos dos fármacos , Isquemia Miocárdica/tratamento farmacológico , Análise de Variância , Animais , Vasos Coronários/fisiologia , Histamina/metabolismo , Modelos Cardiovasculares , Isquemia Miocárdica/metabolismo , Isquemia Miocárdica/fisiopatologia , Reperfusão Miocárdica , Miocárdio/metabolismo , Óxido Nítrico/metabolismo , Ratos , Substâncias Reativas com Ácido Tiobarbitúrico/metabolismo , Vasodilatação/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA